Market Research in the Pharmaceutical Industry: How Pharma Companies Use It

Quick answer: Market research in pharmaceutical industry is how drug companies find out what doctors, patients and payers really think and do, before and after a launch. Teams use interviews, surveys and existing data to decide how to develop, price, position and launch a medicine, and to work out why it isn’t being used when it isn’t.

A drug can take years to develop and still stumble at launch for reasons nobody checked. Doctors saw no reason to switch. Patients quit after three weeks. The hospital formulary said no. Most of those problems could have been spotted earlier, and fixed for a lot less money.

This guide covers how market research for pharmaceutical companies works day to day: who gets interviewed, which methods get used, what the rules are, and how to pick a research partner. It’s written for brand managers, insights teams and founders who commission studies, and for anyone trying to get their head around the field.

What is market research in pharmaceutical industry?

Market research in pharmaceutical industry is simple to describe. You ask the people who shape a medicine’s fate what they think, and you watch what they actually do. That means the doctors who prescribe it, the patients who take it, the payers and hospitals who fund it, and the pharmacists who hand it over. Then you decide using what you learned, instead of guessing. It looks like regular market research, but it behaves differently in three ways.

• The audience is small. You can’t just survey any 300 adults. You might need 60 verified oncologists, and every one of them is busy.
• The subject is sensitive. Health data, side effects and drug promotion rules all shape how a study can run.
• The consequences are bigger. A wrong call can affect patients, not just sales.

That’s why pharma work usually goes to teams who already know healthcare market research, rather than to a general survey vendor.

Why pharmaceutical companies invest in market research

The questions change as a product moves through its life. This is roughly how research fits in at each stage.

None of this replaces clinical evidence. It answers a different question: if the drug works, will people actually use it?

Who do pharma companies research?

• Doctors (HCPs). Specialists and GPs tell you how they diagnose, what they prescribe today and what would make them switch.
• Patients and caregivers. They explain what living with a condition is really like, why people stop treatment, and what they value in a therapy.
• Payers and hospital decision-makers. Insurers, hospital administrators and procurement committees decide what gets covered or stocked.
• Pharmacists and chemists. In India, chemists often influence substitution and what a patient finally buys, so retail pharmacy research matters.
• Key opinion leaders (KOLs). Senior experts whose views shape guidelines and what their peers do.

Verification matters here more than almost anywhere. A survey answered by the wrong “doctor” is worse than no survey, because it looks like evidence. So respondent checks are a big part of any serious study, including any online panel research.

Main methods used in pharma market research

Qualitative research

Interviews and focus groups help you understand why. Why a doctor prefers one therapy. Why patients struggle with a dosing schedule. It’s the right place to start, and the right fallback when a number won’t explain itself. Our qualitative research services cover both.

Quantitative research

Surveys with enough respondents to count and compare. How many doctors would prescribe it? Is awareness moving? Which message lands better? Phone (CATI) and online (CAWI) are the usual routes. Details are on our quantitative research Services, and the quantitative market research guide covers the basics.

Secondary research

Published studies, treatment guidelines, sales data, competitor information. It’s quick and cheap, and it saves you from paying to ask something that’s already been answered. It’s also where most market sizing starts.

Tracking studies

Repeat the same survey with comparable people and you can watch awareness, trial and usage move before and after launch. That needs a consistent respondent base, which is where panel research comes in.

How a pharma market research project works

1. Start with the decision. Not “learn about oncologists”, but “decide whether to position our drug as first-line or second-line.”
2. Pick the method and the audience. Interviews, surveys or both. Specialists, patients or payers.
3. Build the sample and the screener. Specialty, experience, patient volume, city. The screener is what keeps the wrong people out.
4. Run the fieldwork, with quality checks all the way through.
5. Analyse. Look for patterns, differences between segments and anything that surprises you.
6. Report with a recommendation. Say what to do next. A pile of charts isn’t a finding.

A quick example: launching a new diabetes injectable in India

This is an illustration, not a client case. The numbers are made up to show the logic.
Say a company is about to launch a once-weekly injectable for type 2 diabetes. The big question is how to position it against what doctors already prescribe.

They start with 15 or so in-depth interviews with diabetologists and general physicians. The goal isn’t numbers yet. It’s to hear what makes doctors hesitate: the price, patients who dislike needles, the extra follow-up.

Next comes a phone or online survey of around 200 doctors, to find out how many share each worry and which message moves them most. A few interviews with hospital pharmacy heads cover what gets stocked, and at what price.

What comes out isn’t a 90-slide deck. It’s a recommendation: lead with convenience for patients who struggle with daily routines, and have a straight answer ready on cost. That’s what a good study looks like.

Where pharma studies usually get stuck

• Recruitment. Specialists see patients all day, so interviews get squeezed into lunch breaks and late evenings. Build in extra time.
• A screener that’s too tight. Ask for oncologists who treat at least 40 patients a month with one specific drug and you may find five people. Loosen it before fieldwork starts, not halfway through.
• Review loops. Questionnaires often pass through brand, medical and compliance teams. Every round adds days.
• Translation. Patient surveys in several languages need back-translation and testing, which adds time too.

Ethics and compliance: the part you can’t skip

• Adverse events. If a respondent mentions a side effect tied to a specific product, the researcher usually has to pass it to the sponsor’s drug safety team. Settle that process before fieldwork starts.
• Blinding. The sponsor or brand often stays hidden, so answers aren’t biased.
• Honoraria. Pay people fairly for their time, and never link it to what they prescribe.
• Consent and data. People should know what’s collected and why. In India, the Digital Personal Data Protection Act, 2023 applies to the processing of personal data.
• Codes of conduct. ESOMAR and EphMRA publish codes, and many pharma sponsors expect agencies to follow them.
Rules and codes get updated, so check the current position with your compliance team. TeamVisory also publishes its answers to the ESOMAR 37 Questions, a checklist buyers use to assess online sample providers.

In-house or outsourced: who should run the research?

Most pharma companies do both. In-house teams know the product and the strategy. Agencies bring access to verified respondents, extra fieldwork capacity and some healthy distance.

Outsourcing makes the most sense when you need rare specialists, several markets at once, a quick turnaround, or a neutral voice to ask the awkward questions. If India is on your list, this guide to market research fieldwork in India covers what to check before you pick a local partner.

Five mistakes that waste pharma research budgets

1. A vague objective. If nobody can say which decision the study will inform, the report won’t change one.
2. Loose screening. A general physician and a cardiologist think very differently about a heart drug. Don’t mix them in one sample.
3. Leading questions. “How useful is this new benefit?” already tells people what you hope to hear.
4. Forgetting language and region. Patient research in India often needs local-language moderators and questionnaires.
5. No recommendation. Insight only counts when someone knows what to do with it.

How to choose a pharmaceutical market research company in India

When you shortlist partners, ask:

• How do you verify that a respondent is a real, practising doctor?
• Which specialties and cities can you reach, and how quickly?
• How do you handle adverse event reporting and data protection?
• Which fieldwork modes do you run: CATI, CAWI, in-person?
• What quality checks are built into the process?
• Can you share a relevant example or reference?
• Who will actually run my project day to day?

A good partner answers without hesitating. If you’re comparing options, start with our healthcare market research services and see how we work as a market research company in India.

What’s different about pharma research in India

• Doctors have little spare time. Short, scheduled formats complete better than long open sessions.
• Respondents are spread out. Metro doctors can usually be reached online or by phone. Smaller cities may need a different approach.
• Language changes things, especially in patient studies.
• Chemists and stockists shape what actually gets dispensed, so a study that skips them can miss a big part of the picture.

Planning a pharma research study?

Tell us the decision you’re trying to make. We’ll suggest a method, an audience and a realistic scope. Explore our healthcare services research or talk to the TeamVisory team.